What You Should Know:
- Today, Blue Cross and Blue Shield of North Carolina partners
with Carrot Inc. and Virta Health to help address two of the largest ongoing
health issues facing Americans today - smoking and type 2 diabetes.
- Virta and Carrot’s programs will be available to
individual under-65 members and fully insured group members beginning November
2020.
Blue Cross and Blue Shield of North Carolina (Blue Cross NC), today announced it is teaming up with Carrot Inc. and Virta
Read More
Type 2 Diabetes - Chronic Disease Management | News, Analysis, Insights - HIT Consultant
Virta Adds Prediabetes and Obesity Reversal to Services
What You Should Know:
- Virta is expanding its suite of treatment options to
include prediabetes reversal, obesity reversal, and type 2 diabetes management.
- By making this crucial expansion, Virta can scale its
treatment to support the tens of millions of additional patients with
prediabetes and obesity, as provide an on-ramp to reversal for those with T2D
that aren’t yet ready to reverse.
Virta Health, the
leader in type 2 diabetes reversal, today introduced the addition
Read More
NIH Funds First Nationwide Rare and Atypical Diabetes Network
What You Should Know:
- NIH awards funding for Rare and Atypical Diabetes
Network, or RADIANT that will seek to discover the cause of
several unusual forms of diabetes.
- RADIANT plans to screen about 2,000 people with unknown
or atypical forms of diabetes that do not fit the common features of type 1 and
type 2 diabetes.
The National Institute of
Health (NIH), announced this week it is funding a nationwide study with The Rare and Atypical Diabetes
Network (RADIANT) that will seek
Read More
DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care
What You Should Know:
- DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.
- DreaMed uses AI-powered technology to seamlessly treat
patients remotely with its virtual diabetes management service by
Read More
Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform
What You Should Know:
- Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services being offered to patients.
- To date, the company has treated more than a million patients
online for a variety of medical conditions ranging from erectile dysfunction to sinus infections
to depression and anxiety for roughly $25/visit (less than a typical co-pay).
Lemonaid Health,
a convenient, affordable,
Read More
COVID-19 Chronic Condition Patient Population Report
What You Should Know:
Wellframe report finds patients want access to virtual
solutions to help manage their chronic conditions amidst the COVID-19 pandemic.
The survey indicates that the COVID-19 pandemic has had a
significant effect on the chronic condition population by delaying access to
care and exacerbating mental health challenges.
Wellframe, a
provider of Digital Health Management solutions, announced the findings of its COVID-19
Chronic Condition Patient Population Report
Read More
Welldoc Awarded 8th FDA Clearance for Bluestar Medical Device for Diabetes
What You Should Know:
Marks 8th FDA clearance for BlueStar, the only
reimbursable software as a medical device for diabetes that integrates with all
of a patient's existing devices.
Welldoc, revolutionizing digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, announced today that the U.S. Food and Drug Administration (FDA) has cleared an additional feature for the digital health product BlueStar Rx which supports individuals using long-acting
Read More
Non-Invasive Technology for Measuring & Monitoring Liver Fat
As part of the growing awareness about chronic disease, it’s important to understand the relationship between nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and diabetes. As a common complication of Type 2 diabetes and obesity, NAFLD can be overlooked comorbidity.
Diabetes is one of the leading causes of disability and death in the United States. One in 10 Americans have diabetes – more than 30 million people – and
Read More
Omada Health Acquires Telehealth Physical Therapy Company Physera
What You Should Know
Tele-physical therapy company Physera announced that
they are joining Omada Health, a digital health company that offers
programs for chronic disease prevention and management, and mental health
support.
Through the deal, Omada adds Physera’s musculoskeletal
solution to its suite of digital care programs for the prevention and self-management
of diabetes, hypertension, and mental health.
Physera recently launched a
Read More
Why Now’s the Time to Use Connected Health Devices for Diabetes Prevention
It’s no secret that chronic disease remains the leading cause of death worldwide, taking up 90 percent of healthcare spending in the United States. For the last several years, there has been a rise in discussions and research around the promise of connected health devices helping manage and prevent chronic conditions as well as healthcare spending. However, today a number of factors are coming together to make that promise a reality. This includes the improvement of real-world data insights
Read More
